Safety of mRNA COVID-19 vaccines during pregnancy

Lancet Infect Dis. 2022 Nov;22(11):1514-1515. doi: 10.1016/S1473-3099(22)00443-1. Epub 2022 Aug 11.

Authors

Sascha Ellington¹, Christine K Olson²

Affiliations

¹ Field Support Branch, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: sellington@cdc.gov.
² Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.

No abstract available

Publication types

Comment

MeSH terms

COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Female
Humans
Pregnancy
RNA, Messenger / genetics
Vaccination
Vaccines*
Vaccines, Synthetic

Substances

COVID-19 Vaccines
RNA, Messenger
Vaccines
Vaccines, Synthetic